COVID-19: Advice for people living with Pulmonary Fibrosis
This fact sheet provides general information and advice for people living with Pulmonary Fibrosis on how to stay safe during the COVID-19 pandemic.
View more25 February 2021 – Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) Consensus Statement on COVID-19 Vaccination for Adults Living with Interstitial Lung Disease (ILD)
The CRE-PF COVID-19 Working Group is strongly supportive of the Australian Government rollout of Therapeutic Goods Administration (TGA) approved COVID-19 vaccines. This includes support of COVID-19 vaccination for adults living with interstitial lung disease who may be immunocompromised.